This inventor holds 42 USPTO granted patents and 22 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Topical Agents. Top assignees: University of California, Iview Therapeutics, Inc., Highfive Technologies, Inc.. Active years: 1984-2026.
Location History:
- El Cerrito, CA (US) (1984 - 1989)
- Palo Alto, CA (US) (2016)
- Berkeley, CA (2018)
- Berkeley, CA (US) (1992 - 2024)
Company Filing History:
14 out of 15,977 
3 out of 9 
1 out of 1 Years Active: 1984-2026
Areas of Expertise:
Title: Edward Tak Wei: Pioneering Innovations in Therapeutic Compounds
Introduction: Edward Tak Wei, a visionary inventor based in Berkeley, CA, has dedicated his career to pushing the boundaries of innovation in the field of therapeutic compounds. With an impressive portfolio of 38 patents, his groundbreaking work continues to revolutionize the treatment of various disorders and diseases.
Latest Patents: Edward Tak Wei's latest patents focus on the development of Di-isopropyl-phosphinoyl-alkanes (DAPA) compounds as topical agents for the treatment of sensory discomfort. These compounds have shown remarkable potential in addressing conditions such as skin dysesthesia, dermatitis, psoriasis, and cognitive dysfunction. Additionally, his work on treating upper aerodigestive tract disorders and cough with compounds like DIPA-1-9 has opened up new possibilities for targeted and effective therapies.
Career Highlights: Throughout his illustrious career, Edward Tak Wei has demonstrated a keen eye for innovation and a relentless pursuit of excellence. With a deep understanding of pharmaceutical compositions and therapeutic compounds, he has successfully translated his research into practical solutions that benefit patients around the world. His contributions have earned him widespread recognition as a trailblazer in the field of medical innovation.
Collaborations: Edward Tak Wei has collaborated with esteemed colleagues such as Holly A. Thomas and Guennady P. Vlasov during his tenure at renowned institutions like the University of California. These partnerships have not only enriched his research efforts but have also fostered a culture of creativity and collaboration within the scientific community.
Conclusion: Edward Tak Wei's passion for innovation and his commitment to improving healthcare have left an indelible mark on the field of therapeutic compounds. His trailblazing work serves as a testament to the power of ingenuity and serves as an inspiration for future generations of inventors. Edward Tak Wei's legacy will continue to shape the future of technology and healthcare in remarkable ways, driving progress and innovation for years to come.